–Published in peer-reviewed Journal of the American College of Cardiology: Heart Failure
Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the publication of the REDUCE FMR clinical study of its Carillon Mitral Contour System(R). The Carillon(R) System is a right heart transcatheter mitral valve repair (TMVr) device designed to treat the primary cause of FMR in patients with MR grades 2+, 3+ and 4+.
“We know that mitral regurgitation in the context of heart failure is strongly associated with increased morbidity and mortality,”
/Public Release.
